Message From the Editor-in-Chief
Message From the Editor-in-Chief
2015 年 79 巻 8 号 p. 1645-1646
詳細
2015 年 79 巻 8 号 p. 1645-1646
Dear Colleagues,
On behalf of the Circulation Journal, I am pleased to report the official 2014 impact factor and the Circulation Journal papers (2012–2013) most frequently quoted in 2014, that substantially contributed to the 2014 impact factor of the Journal.
I am pleased to report that Circulation Journal has earned an official 2014 Impact Factor (IF) of 3.940. The official ranking also places Circulation Journal 31st among the 123 journals in the Cardiac & Cardiovascular Systems category in 2014 JCR Science Edition (36th among the 125 journals in 2013) (Figure).
The Circulation Journal, the official journal of the Japanese Circulation Society (JCS), should represent the Asia/Pacific region, similar to the Circulation, published by the American Heart Association (AHA), the Journal of the American College of Cardiology, published by the American College of Cardiology (ACC), both in America, and the European Heart Journal, published by the European Society of Cardiology (ESC), in Europe. Numbers in the parentheses show the 2014 impact factor of the Journals.
The following papers, published in 2012–2013, were among the top 30 most frequently quoted papers in 2014, thereby substantially contributing to the 2014 Impact Factor of the Journal (number in the parenthesis denoted the number of quotation in 2012–2013).
1. (47) Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al; on behalf of the J-ROCKET AF study investigators. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation: The J-ROCKET AF Study. Circ J 2012; 76: 2104–2111.
2. (22) Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, et al; on behalf of the J-RHYTHM Registry investigators. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: Results of the J-RHYTHM Registry. Circ J 2013; 77: 2264–2270.
(22) Matsubara J, Sugiyama S, Akiyama E, Iwashita S, Kurokawa H, Ohba K, et al. Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes. Circ J 2013; 77: 1337–1344.
(22) Swift DL, Lavie CJ, Johannsen NM, Arena R, Earnest CP, O’Keefe JH, et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 2013; 77: 281–292.
5. (21) Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485–488.
6. (19) Takigiku K, Takeuchi M, Izumi C, Yuda S, Sakata K, Ohte N, et al; on behalf of the JUSTICE investigators. Normal range of left ventricular 2-dimensional srain: Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) Study. Circ J 2012; 76: 2623–2632.
(19) Berne P, Brugada J. Brugada syndrome 2012. Circ J 2012; 76: 1563–1571.
8. (18) Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J 2012; 76: 1054–1065.
9. (17) Simon DI. Inflammation and vascular injury: Basic discovery to drug development. Circ J 2012; 76: 1811–1818.
10. (15) Elrod JW, Molkentin JD. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ J 2013; 77: 1111–1122.
(15) Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim TH, et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury: A systematic review and meta-analysis. Circ J 2012; 76: 2255–2265.
(15) Chung SY, Sheu JJ, Lin YJ, Sun CK, Chang LT, Chen YL, et al. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support: A single-center observational study. Circ J 2012; 76: 1385–1392.
(15) Kume T, Okura H, Miyamoto Y, Yamada R, Saito K, Tamada T, et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation: Preliminary observation. Circ J 2012; 76: 698–703.
14. (14) Fukumoto Y, Yamada N, Matsubara H, Mizoguchi M, Uchino K, Yao A, et al. Double-blind, placebo-controlled clinical trial with a Rho-kinase inhibitor in pulmonary arterial hypertension: A pilot efficacy trial. Circ J 2013; 77: 2619–2625.
(14) Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al; on behalf of the ATTEND investigators. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 2013; 77: 944–951.
(14) Minamino T. Cardioprotection from ischemia/reperfusion injury: Basic and translational research. Circ J 2012; 76: 1074–1082.
17. (13) Annema W, von Eckardstein A. High-density lipoproteins: Multifunctional but vulnerable protections from atherosclerosis. Circ J 2013; 77: 2432–2448.
(13) Satoh K, Fukumoto Y, Sugimura K, Miura Y, Aoki T, Nochioka K, et al. Plasma cyclophilin a is a novel biomarker for coronary artery disease. Circ J 2013; 77: 447–455.
(13) Ishihara M. Acute hyperglycemia in patients with acute myocardial infarction. Circ J 2012; 76: 563–571.
20. (12) Ohira T, Iso H. Cardiovascular disease epidemiology in Asia: An overview. Circ J 2013; 77: 1646–1652.
(12) Watanabe I, Tatebe J, Namba S, Koizumi M, Yamazaki J, Morita T. Activation of aryl hydrocarbon receptor mediates indoxyl sulfate-induced monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells. Circ J 2013; 77: 224–230.
(12) Veerakul G, Nademanee K. Brugada syndrome: Two decades of progress. Circ J 2012; 76: 2713–2722.
(12) Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, et al. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation. Circ J 2012; 76: 2337–2342.
(12) Yamashita T, Koretsune Y, Yasaka M, Inoue H, Kawai Y, Yamaguchi T, et al. Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation. Circ J 2012; 76: 1840–1847.
(12) Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, et al. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J 2012; 76: 423–429.
26. (11) Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J 2013; 77: 2419–2431.
(11) Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J 2013; 77: 2209–2217.
(11) Takano H, Mizuma H, Kuwabara Y, Sato Y, Shindo S, Kotooka N, et al; on behalf of the PEARL Study investigators. Effects of pitavastatin in Japanese patients with chronic heart failure: The Pitavastatin Heart Failure Study (PEARL Study). Circ J 2013; 77: 917–925.
(11) Oldenburg O. Cheyne-stokes respiration in chronic heart failure: Treatment with adaptive servoventilation therapy. Circ J 2012; 76: 2305–2317.
(11) Feigenbaum H, Mastouri R, Sawada S. A practical approach to using strain echocardiography to evaluate the left ventricle. Circ J 2012; 76: 1550–1555.
The Editorial Team looks forward to receiving manuscripts with high scientific impact from all over the world.
(Released online July 14, 2015)
